Scinvivo
Eindhoven, NL · Founded 2016 · 18 employees on LinkedIn · 1 known investors
Scinvivo develops Lumante, a catheter-based optical coherence tomography (OCT) imaging platform for real-time, minimally invasive visualization and local staging of bladder cancer during cystoscopy. The system, aimed at urologists, has received FDA Breakthrough Device Designation and is in pre-clinical/clinical development.
Founders & leadership
Scinvivo was founded in 2016 by Marijn van Os and Diederik van Lierop.
Investors · 1
Frequently asked questions
- What does Scinvivo do?
- Scinvivo develops Lumante, a catheter-based optical coherence tomography (OCT) imaging platform for real-time, minimally invasive visualization and local staging of bladder cancer during cystoscopy. The system, aimed at urologists, has received FDA Breakthrough Device Designation and is in pre-clinical/clinical development.
- Who founded Scinvivo?
- Scinvivo was founded by Marijn van Os, Diederik van Lierop in 2016.
- Who are Scinvivo's investors?
- Scinvivo's investors include NLC.
- Where is Scinvivo headquartered?
- Scinvivo is headquartered in Eindhoven, NL.